Literature DB >> 25117872

What's behind a sand fly bite? The profound effect of sand fly saliva on host hemostasis, inflammation and immunity.

Maha Abdeladhim1, Shaden Kamhawi2, Jesus G Valenzuela3.   

Abstract

Sand flies are blood-feeding insects and vectors of the Leishmania parasite. For many years, saliva of these insects has represented a gold mine for the discovery of molecules with anti-hemostatic and immuno-modulatory activities. Furthermore, proteins in sand fly saliva have been shown to be a potential vaccine against leishmaniasis and also markers of vector exposure. A bottleneck to progress in these areas of research has been the identification of molecules responsible for the observed activities and properties of saliva. Over the past decade, rapid advances in transcriptomics and proteomics resulted in the completion of a number of sialomes (salivary gland transcriptomes) and the expression of several recombinant salivary proteins from different species of sand fly vectors. This review will provide readers with a comprehensive update of recent advances in the characterization of these salivary molecules and their biological activities and offer insights pertaining to their protective effect against leishmaniasis and their potential as markers of vector exposure. Published by Elsevier B.V.

Entities:  

Keywords:  Immunity; Leishmaniasis; Salivary protein; Sand flies; Transcriptomes; Vaccine

Mesh:

Substances:

Year:  2014        PMID: 25117872      PMCID: PMC4562216          DOI: 10.1016/j.meegid.2014.07.028

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  89 in total

1.  From transcriptome to immunome: identification of DTH inducing proteins from a Phlebotomus ariasi salivary gland cDNA library.

Authors:  Fabiano Oliveira; Shaden Kamhawi; Amy E Seitz; Van My Pham; Pierre M Guigal; Laurent Fischer; Jerrold Ward; Jesus G Valenzuela
Journal:  Vaccine       Date:  2005-08-15       Impact factor: 3.641

2.  Genetic variation in the sand fly salivary protein, SP-15, a potential vaccine candidate against Leishmania major.

Authors:  D-E A Elnaiem; C Meneses; M Slotman; G C Lanzaro
Journal:  Insect Mol Biol       Date:  2005-04       Impact factor: 3.585

3.  Lutzomyia longipalpis saliva drives apoptosis and enhances parasite burden in neutrophils.

Authors:  Deboraci Brito Prates; Théo Araújo-Santos; Nívea Farias Luz; Bruno B Andrade; Jaqueline França-Costa; Lilian Afonso; Jorge Clarêncio; José Carlos Miranda; Patrícia T Bozza; George A Dosreis; Cláudia Brodskyn; Manoel Barral-Netto; Valéria Matos Borges; Valéria de Matos Borges; Aldina Barral
Journal:  J Leukoc Biol       Date:  2011-06-17       Impact factor: 4.962

4.  Evaluation of recombinant Leishmania polyprotein plus glucopyranosyl lipid A stable emulsion vaccines against sand fly-transmitted Leishmania major in C57BL/6 mice.

Authors:  Nathan C Peters; Sylvie Bertholet; Phillip G Lawyer; Melanie Charmoy; Audrey Romano; Flavia L Ribeiro-Gomes; Lisa W Stamper; David L Sacks
Journal:  J Immunol       Date:  2012-10-08       Impact factor: 5.422

5.  In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies.

Authors:  Nathan C Peters; Jackson G Egen; Nagila Secundino; Alain Debrabant; Nicola Kimblin; Shaden Kamhawi; Phillip Lawyer; Michael P Fay; Ronald N Germain; David Sacks
Journal:  Science       Date:  2008-08-15       Impact factor: 47.728

6.  Phlebotomine salivas inhibit immune inflammation-induced neutrophil migration via an autocrine DC-derived PGE2/IL-10 sequential pathway.

Authors:  Vanessa Carregaro; Jesus G Valenzuela; Thiago M Cunha; Waldiceu A Verri; Renata Grespan; Graziela Matsumura; José M C Ribeiro; Dia-Eldin Elnaiem; João S Silva; Fernando Q Cunha
Journal:  J Leukoc Biol       Date:  2008-04-07       Impact factor: 4.962

7.  Lufaxin, a novel factor Xa inhibitor from the salivary gland of the sand fly Lutzomyia longipalpis blocks protease-activated receptor 2 activation and inhibits inflammation and thrombosis in vivo.

Authors:  Nicolas Collin; Teresa C F Assumpção; Daniella M Mizurini; Dana C Gilmore; Angélica Dutra-Oliveira; Michalis Kotsyfakis; Anderson Sá-Nunes; Clarissa Teixeira; José M C Ribeiro; Robson Q Monteiro; Jesus G Valenzuela; Ivo M B Francischetti
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-07-12       Impact factor: 8.311

8.  LBSapSal-vaccinated dogs exhibit increased circulating T-lymphocyte subsets (CD4⁺ and CD8⁺) as well as a reduction of parasitism after challenge with Leishmania infantum plus salivary gland of Lutzomyia longipalpis.

Authors:  Rodrigo Dian de Oliveira Aguiar-Soares; Bruno Mendes Roatt; Henrique Gama Ker; Nádia das Dores Moreira; Fernando Augusto Siqueira Mathias; Jamille Mirelle de Oliveira Cardoso; Nelder Figueiredo Gontijo; Oscar Bruna-Romero; Andréa Teixeira-Carvalho; Olindo Assis Martins-Filho; Rodrigo Corrêa-Oliveira; Rodolfo Cordeiro Giunchetti; Alexandre Barbosa Reis
Journal:  Parasit Vectors       Date:  2014-02-07       Impact factor: 3.876

9.  Salivary antigen SP32 is the immunodominant target of the antibody response to Phlebotomus papatasi bites in humans.

Authors:  Soumaya Marzouki; Maha Abdeladhim; Chaouki Ben Abdessalem; Fabiano Oliveira; Beya Ferjani; Dana Gilmore; Hechmi Louzir; Jesus G Valenzuela; Mélika Ben Ahmed
Journal:  PLoS Negl Trop Dis       Date:  2012-11-29

10.  Seroconversion of sentinel chickens as a biomarker for monitoring exposure to visceral leishmaniasis.

Authors:  Bárbara Ribeiro Soares; Ana Paula Almeida Souza; Deboraci Brito Prates; Camila I de Oliveira; Manoel Barral-Netto; José Carlos Miranda; Aldina Barral
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more
  50 in total

1.  Human immune response to salivary proteins of wild-caught Phlebotomus papatasi.

Authors:  Rami M Mukbel; Rehab H Khasharmeh; Nawal S Hijjawi; Mohammed S Khalifeh; Ma'mon M Hatmal; Mary Ann McDowell
Journal:  Parasitol Res       Date:  2016-05-10       Impact factor: 2.289

2.  Human immune response to Phlebotomus sergenti salivary gland antigens in a leishmaniasis-endemic focus in Iran.

Authors:  Arshad Veysi; Ahmad Reza Mahmoudi; Mohammad Reza Yaghoobi-Ershadi; Mahmood Jeddi-Tehrani; Yavar Rassi; Alireza Zahraei-Ramazani; Nasibeh Hosseini-Vasoukolaei; Bushra Zareie; Ali Khamesipour; Amir Ahmad Akhavan
Journal:  Pathog Glob Health       Date:  2020-07-09       Impact factor: 2.894

3.  Gut Microbes Egested during Bites of Infected Sand Flies Augment Severity of Leishmaniasis via Inflammasome-Derived IL-1β.

Authors:  Ranadhir Dey; Amritanshu B Joshi; Fabiano Oliveira; Lais Pereira; Anderson B Guimarães-Costa; Tiago D Serafim; Waldionê de Castro; Iliano V Coutinho-Abreu; Parna Bhattacharya; Shannon Townsend; Hamide Aslan; Alec Perkins; Subir Karmakar; Nevien Ismail; Morgan Karetnick; Claudio Meneses; Robert Duncan; Hira L Nakhasi; Jesus G Valenzuela; Shaden Kamhawi
Journal:  Cell Host Microbe       Date:  2017-12-28       Impact factor: 21.023

4.  Exploring the relationship between susceptibility to canine leishmaniosis and anti-Phlebotomus perniciosus saliva antibodies in Ibizan hounds and dogs of other breeds in Mallorca, Spain.

Authors:  Alexis C Burnham; Laura Ordeix; M Magdalena Alcover; Pamela Martínez-Orellana; Sara Montserrat-Sangrà; Laura Willen; Tatiana Spitzova; Petr Volf; Laia Solano-Gallego
Journal:  Parasit Vectors       Date:  2020-04-21       Impact factor: 3.876

5.  Increased Transmissibility of Leishmania donovani From the Mammalian Host to Vector Sand Flies After Multiple Exposures to Sand Fly Bites.

Authors:  Joanna G Valverde; Andrea Paun; Ehud Inbar; Audrey Romano; Michael Lewis; Kashinath Ghosh; David Sacks
Journal:  J Infect Dis       Date:  2017-04-15       Impact factor: 5.226

Review 6.  Leishmania vaccine development: exploiting the host-vector-parasite interface.

Authors:  S G Reed; R N Coler; D Mondal; S Kamhawi; J G Valenzuela
Journal:  Expert Rev Vaccines       Date:  2015-11-23       Impact factor: 5.217

7.  Phlebotomus papatasi Yellow-Related and Apyrase Salivary Proteins Are Candidates for Vaccination against Human Cutaneous Leishmaniasis.

Authors:  Aymen Tlili; Soumaya Marzouki; Emna Chabaane; Maha Abdeladhim; Wafa Kammoun-Rebai; Rahma Sakkouhi; Nabil Belhadj Hmida; Fabiano Oliveira; Shaden Kamhawi; Hechmi Louzir; Jesus G Valenzuela; Mélika Ben Ahmed
Journal:  J Invest Dermatol       Date:  2017-10-17       Impact factor: 8.551

8.  Prevalence of and Factors Associated with Negative Microscopic Diagnosis of Cutaneous Leishmaniasis in Rural Peru.

Authors:  Ryan Lamm; Clark Alves; Grace Perrotta; Meagan Murphy; Catherine Messina; Juan F Sanchez; Erika Perez; Luis Angel Rosales; Andres G Lescano; Edward Smith; Hugo Valdivia; Jack Fuhrer; Sarah-Blythe Ballard
Journal:  Am J Trop Med Hyg       Date:  2018-05-31       Impact factor: 2.345

9.  A sand fly salivary protein acts as a neutrophil chemoattractant.

Authors:  Anderson B Guimaraes-Costa; John P Shannon; Ingrid Waclawiak; Jullyanna Oliveira; Claudio Meneses; Waldione de Castro; Xi Wen; Joseph Brzostowski; Tiago D Serafim; John F Andersen; Heather D Hickman; Shaden Kamhawi; Jesus G Valenzuela; Fabiano Oliveira
Journal:  Nat Commun       Date:  2021-05-28       Impact factor: 14.919

Review 10.  Potential biomarkers of immune protection in human leishmaniasis.

Authors:  Mahmoud Nateghi Rostami; Ali Khamesipour
Journal:  Med Microbiol Immunol       Date:  2021-05-02       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.